Forbes: Trump Doesn’t Know Who ‘Middlemen’ Are, But PBMs Okay With His Drug Price Agenda

Forbes: Trump Doesn’t Know Who ‘Middlemen’ Are, But PBMs Okay With His Drug Price Agenda

“We support (the administration’s) call for greater flexibility in benefit design to encourage better price negotiations, including allowing Medicare Part D plan sponsors to promote lower cost generics and biosimilars,”